免疫基生物标志物作为严重COVID-19ARDS的ECMO治疗中的死亡率预测者:从回顾性研究的见解
Rosalia Busà1, Giovanna Panarello1, Alessia Gallo1
1IRCCS ISMETT, 90127 Palermo, Italy.
International journal of molecular sciences
|January 10, 2026
概括
识别T细胞枯竭,低干扰素α和高calprotectin等免疫标记物可以预测需要体外膜氧化 (ECMO) 治疗严重COVID-19的患者的死亡风险更高. 这有助于ECMO患者的选择.
科学领域:
- 关键护理医学 关键护理医学
- 免疫学 免疫学 免疫学
- 传染病 传染病 传染病
背景情况:
- 身体外膜氧化 (ECMO) 对于严重的呼吸衰竭至关重要,特别是在急性呼吸困扰综合征 (ARDS) 中.
- 对ECMO患者的选择仍然具有挑战性,需要改进符合条件的标准.
- 预测经过ECMO的重症患者的结果对于资源配置和治疗策略至关重要.
研究的目的:
- 确定新的基于免疫的生物标志物,以评估COVID-19患者的ECMO资格.
- 预测需要ECMO支持的重症COVID-19患者的结果.
- 加强患者选择,指导ECMO治疗的治疗决策.
主要方法:
- 对80名需要ECMO的严重COVID-19患者进行了回顾性观察队列研究.
- 使用机器学习分析临床数据,细胞因子水平,RNA测序和免疫细胞概况.
- 在入院后两天内对感染原始SARS-CoV-2菌株的患者进行生物标志物评估.
主要成果:
- 结合T细胞耗尽,低干扰素α (IFNα) 和高calprotectin水平,发现死亡风险增加了5.56倍.
- 这些免疫标志物与ECMO患者的较差结果显著相关.
- 机器学习确定了与ECMO患者预后相关的特定免疫特征.
结论:
- 免疫分析对ECMO患者的选择和严重COVID-19的结果预测至关重要.
- 新的基于免疫的生物标志物可以改善ECMO资格评估.
- 将这些生物标志物整合到临床实践中可能会改善患者管理和结果.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
782
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
782
01:21Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
308
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
308
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531